| The Pharmacogenomic HLA Biomarker Associated to Adverse Abacavir Reactions: Comparative Analysis of Different Genotyping Methods |
joseu |
Oct 5, 2016 4:14:42 AM |
| Genotyping for Severe Drug Hypersensitivity |
joseu |
Oct 5, 2016 4:14:14 AM |
| Hypersensitivity Reaction Associated with Abacavir Therapy in an Indian HIV Patient – A Case Report |
joseu |
Oct 5, 2016 4:01:14 AM |
| Prevalence of HLA-B*5701 and Its Relationship with Abacavir Hypersensitivity Reaction in Iranian HIV-Infected Patients |
joseu |
Oct 5, 2016 3:54:45 AM |
| Prevalence of HLA-B*5701 and Its Relationship with Abacavir Hypersensitivity Reaction in Iranian HIV-Infected Patients |
soy_melina |
Oct 4, 2016 11:24:55 PM |
| Abacavir propiedades y aplicaciones |
isabelsalinas_ |
Oct 2, 2016 5:01:11 AM |
| Antiviral efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV-infected children and adolescents: a systematic review protocol |
MarcelaRodas |
Oct 1, 2016 12:38:05 AM |
| Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan |
MarcelaRodas |
Oct 1, 2016 12:36:58 AM |
| Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel |
MarcelaRodas |
Oct 1, 2016 12:32:28 AM |
| Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis |
MarcelaRodas |
Sep 30, 2016 11:53:53 PM |